Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Do people with and without medical conditions respond similarly to the Short Health Anxiety Inventory? An assessment of differential item functioning using item response theory.
4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer.
Immune-Reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases.
Unilateral ankle dorsiflexor spasticity: an uncommon, disabling complication of transverse myelitis.
Recombinant Expression of Margatoxin and Agitoxin-2 in Pichia pastoris: An Efficient Method for Production of K(V)1.3 Channel Blockers.
Interaction between HLA-DRB1-DQB1 Haplotypes in Sardinian Multiple Sclerosis Population.
Unemployment in multiple sclerosis (MS): utility of the MS Functional Composite and cognitive testing.
Vitamin D status and the risk of multiple sclerosis: A systematic review and meta-analysis.
Minocycline attenuates experimental autoimmune encephalomyelitis in rats by reducing T cell infiltration into the spinal cord.
Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis.
Interleukin-2 and the brain: dissecting central versus peripheral contributions using unique mouse models.
Progressive multiple sclerosis and mood disorders.
Continuous prediction of secondary progression in the individual course of multiple sclerosis.
Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies.
Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis.
Cutting Edge: IL-6-Dependent Autoimmune Disease: Dendritic Cells as a Sufficient, but Transient, Source.
The CSF JCV antibody index for diagnosis of natalizumab-associated PML.
Decrease in newly generated oligodendrocytes leads to motor dysfunctions and changed myelin structures that can be rescued by transplanted cells.
Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis.
Cerebrospinal fluid α-synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase.
Treatment of Acute Disseminated Encephalomyelitis.
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial.
Validation of a new quality of life scale related to multiple sclerosis and relapses.
Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis.
Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern.

Pages